Anwendungsgebiet
Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise: as monotherapy when metformin is considered inappropriate due to intolerance or contraindications; in addition to other medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.
In anderen Ländern
Dieselben Wirkstoffe in anderen Registern, dieselbe Marke zuerst.
Nationale Einträge
Die nationalen Register, in denen dieses EU-Arzneimittel aufgeführt ist.
- Ozempic 0,5 MG Solucion Inyectable en Pluma PrecargadaSpanien · 1,34 mgIm Handel
- Ozempic 1 MG Solucion Inyectable en Pluma PrecargadaSpanien · 1 mg/dosisIm Handel
- Ozempic 2 MG Solucion Inyectable en Pluma PrecargadaSpanien · 2,68 mg/mlZugelassen
- Ozempic 0,25 mg oplossing voor injectie in een voorgevulde penNiederlande